Role of miRNAs in Epicardial Adipose Tissue in CAD Patients with T2DM
Table 1
Baseline characteristics of patients.
Non-CAD + T2DM ()
CAD + T2DM ()
value
Age (years)
61.8 ± 5.2
54.6 ± 7.0
0.392
BMI (kg/m2)
29.47 ± 5.83
28.63 ± 4.26
0.213
WC (cm)
99.64 ± 10.67
101.23 ± 10.34
0.492
Waist-hip ratio
0.96 ± 0.14
0.99 ± 0.09
<0.001
FPG (mg/dL)
106.5 (98.5–115.5)
116.0 (100.5–138.0)
0.103
Total cholesterol
166.48 ± 37.10
159.55 ± 39.41
0.335
LDL-C (mg/dL)
93.51 ± 26.59
98.44 ± 23.14
<0.01
HDL-C (mg/dL)
40.66 ± 10.08
34.39 ± 9.64
<0.01
Triglyceride (mg/dL)
139 (105.5–223.5)
154 (106.0–234.0)
0.276
hsCRP (mg/dL)
1.03 ± 2.31
3.15 ± 5.22
<0.001
Adiponectin (μg/mL)
12.37 ± 6.55
9.16 ± 4.78
<0.05
Fibrinogen (mg/dL)
523.0 (453.0–638.0)
603.5 (510.5–766.5)
<0.01
FPG: fasting plasma glucose, LDL-C: low density lipoprotein cholesterol, HDL-C: high density lipoprotein cholesterol, and hsCRP: hypersensitive C reactive protein. Adiponectin, hsCRP, and fibrinogen indicate systemic inflammation.
